Prospects for using systemic magnetotherapy in treatment of patients with benign prostatic hyperplasia

This article discusses the results of treatment of BPH with systemic magnetotherapy. The study included 206 patients diagnosed with BPH on the basis of the urological department of the Medical Company "Moya Nauka". For a comparative assessment of the effectiveness of the tactics, the following indicators were selected: the volume of the prostate gland according to TRUS, uroflowmetry, the post-void residual, and the levels of IPSS and PSA. It has been determined that the volume of the prostate gland tends to decrease after the use of systemic magnetotherapy. The post-void residual, IPSS scores, and PSA levels reduce as well. The rate of uroflowmetry increases approaching the normal value.